Ruba Altahla | Orthopedic Rehabilitation | Best Research Article Award

Posted on by Pencis

Dr. Ruba Altahla | Orthopedic Rehabilitation | Best Research Article Award

Dr.  Ruba Altahla , Huazhong University of Science and Technology, China.
Ruba Altahla is a researcher specializing in Orthopedic Rehabilitation. She has made significant contributions to the field through her studies on rehabilitation techniques aimed at improving patient outcomes after orthopedic surgeries. Her research focuses on developing innovative, evidence-based approaches to restore mobility and functionality in patients with musculoskeletal injuries.

Profile:

Scopus Profile

Education 

Dr. Ruba Altahla earned her Master’s degree in Physical Therapy and Rehabilitation Medicine from the Medical College at Huazhong University of Science and Technology, Tongji, in 2021. Prior to that, she completed a one-year diploma in Chinese language at the same institution in 2017. Dr. Altahla holds a Bachelor’s degree in Physiotherapy, which she obtained from Al-Baath University, Faculty of Health Science, in 2012.

 

Experience 

Dr. Ruba Altahla has extensive clinical experience in physiotherapy and rehabilitation medicine. She completed her clinical training at Wuhan Tongji Hospital from September 2018 to 2021. Prior to that, she volunteered as a home-based care physical therapist with Mawadah Community Center and Al Baer Social Association, both funded by UNHCR, from June 2016 to July 2017. In addition to her clinical work, Dr. Altahla has teaching experience at Al-Baath University, where she supervised practical sessions for courses including Physiology of the Neurological and Muscular Systems, Rehabilitation for Amputees, Electrotherapy, and Rehabilitation of Joint Diseases between 2013 and 2017. She also supervised practical sections in the Department of Chemistry during the 2013-2014 academic year. Dr. Altahla has attended several courses and conferences, including the International Computer Driving License (ICDL), an English language course, and international courses in physiotherapy and occupational therapy. She also completed a Clinical Applications of Epidemiology course in July 2021.

Top Note Publications

Article: Thioredoxin-Interacting Protein’s Role in NLRP3 Activation and Osteoarthritis Pathogenesis by Pyroptosis Pathway: In Vivo Study
Author: Altahla, R., & Xu, T.
Journal: Metabolites
Year: 2024

Article: Ferroptosis plays a role in osteoarthritis
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: All Life
Year: 2024

Article: A cross-sectional survey on the effects of the COVID-19 pandemic on psychological well-being and quality of life in people with spinal cord injury
Author: Altahla, R., Alshorman, J., Ali, I., & Xu, T.
Journal: Journal of Orthopaedic Surgery and Research
Year: 2024

Article: The impact of COVID-19 on epidemiological features of spinal cord injury in Wuhan, China: a comparative study in different time periods
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: Medicina
Year: 2023

Article: Epidemiological characteristics: traumatic cervical spinal cord injury in Wuhan-China
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: Academia Medicine
Year: 2024

Article: Guidelines for treating spinal cord injury without radiological abnormalities in children
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: INNOSC Theranostics and Pharmacological Sciences
Year: 2023

Article: Prevalence of Musculoskeletal Disorders and Associated Work-related Risk Factors in Chinese Physiotherapists: A Comparative Study
Author: Altahla, R., Alshorman, J., & Xu, T.
Journal: ALANBAR Medical Journal
Year: 2024

Article: Recommendations on the management and prevention of spinal cord injury in children following backbend dance
Author: Alshorman, J., Altahla, R., & Xu, T.
Journal: INNOSC Theranostics and Pharmacological Sciences
Year: 2024

Reigner Jay Escartin | HIV-1 | Best Researcher Award-duplicate-1

Posted on by Pencis

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Mr. Reigner Jay Escartin , University of the Immaculate Conception, Philippines.

Mr. Reigner Jay Escartin is an accomplished researcher specializing in HIV-1 studies. His groundbreaking work has significantly advanced the understanding of the virus, focusing on treatment strategies and viral pathogenesis. His dedication to HIV research has earned him the prestigious Best Researcher Award, recognizing his contributions to global health and scientific innovation. Escartin’s research continues to impact the fight against HIV/AIDS, with a commitment to improving patient outcomes and advancing therapeutic approaches.

Profile:

Orcid  Profile

Education and Experience

Mr. Reigner Jay Escartin holds a Bachelor of Science in Medical Technology/Medical Laboratory Science from the University of the Immaculate Conception. He completed his Medical Technology internship at Davao Doctors Hospital (2022–2023) and is currently pursuing a Master of Science in Medical Technology, majoring in Biomedical Sciences (2023–present). Mr. Escartin serves as a full-time faculty member and clinical instructor at his alma mater. He is a registered member of PAMET, PAPSI, and the Philippine Association of Schools of Medical Technology and Public Health, Inc. Additionally, he holds a Lean Six Sigma White Belt certification, reflecting his commitment to continuous improvement in the field.

 

Areas of Research

Mr. Reigner Jay Escartin’s primary research area focuses on HIV-1, with a notable contribution to understanding the success rates and adherence to antiretroviral therapy (ART) among treatment-naïve patients in Davao City, Philippines. His work is highlighted by a ten-year retrospective cohort study that examined the long-term effectiveness of ART, analyzing patient adherence and identifying key factors that influence treatment outcomes. Through this research, Mr. Escartin has contributed valuable insights into the challenges faced by HIV-1 patients in adhering to therapy, particularly within local contexts. His findings aim to improve healthcare delivery and patient support systems, ultimately enhancing the quality of life for individuals living with HIV. Although still early in his career, his commitment to research and innovation in HIV-1 therapy provides a foundation for future development and collaboration in both clinical and public health settings. By addressing real-world issues in HIV treatment, his work is poised to drive further research and extension activities that could have a lasting impact on patient care and treatment protocols in the region.

Research and Innovations

Mr. Reigner Jay Escartin has completed one ongoing research project, though he currently has no consultancy or industry-sponsored projects, and the total cost of his projects is not applicable. He has published one journal article indexed in Scopus, Web of Science, or PubMed, but has no publications in SCI or SCIE indexes. He has not yet published any books, chapters, or conference proceedings, nor has he filed any patents. Additionally, he holds no editorial appointments in journals or conferences and has no citation index, H-index, or cumulative impact factor in the past three years. He has not presented at conferences, served as an invited speaker or resource person, or organized any research conferences or workshops. Mr. Escartin has not visited other countries for research, has not graduated any research scholars, and has no ongoing scholars under his supervision. He is also not involved in collaborative research activities, holds no awards or recognitions, and has not established functional MoUs with other institutions or industries. Lastly, he is not a member of any professional bodies.

Top Note Publications

Escartin, R. J. (2024, December). Success rates and adherence to antiretroviral therapy among treatment-naïve patients in Davao City, Philippines: A ten-year retrospective cohort study. Dialogues in Health, ISSN 2772-6533. https://doi.org/10.1016/j.dialog.2024.100195

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Posted on by Pencis

Reigner Jay Escartin | HIV-1 | Best Researcher Award

Mr. Reigner Jay Escartin , University of the Immaculate Conception, Philippines.

Mr. Reigner Jay Escartin is an accomplished researcher specializing in HIV-1 studies. His groundbreaking work has significantly advanced the understanding of the virus, focusing on treatment strategies and viral pathogenesis. His dedication to HIV research has earned him the prestigious Best Researcher Award, recognizing his contributions to global health and scientific innovation. Escartin’s research continues to impact the fight against HIV/AIDS, with a commitment to improving patient outcomes and advancing therapeutic approaches.

Profile:

Orcid  Profile

Education and Experience

Mr. Reigner Jay Escartin holds a Bachelor of Science in Medical Technology/Medical Laboratory Science from the University of the Immaculate Conception. He completed his Medical Technology internship at Davao Doctors Hospital (2022–2023) and is currently pursuing a Master of Science in Medical Technology, majoring in Biomedical Sciences (2023–present). Mr. Escartin serves as a full-time faculty member and clinical instructor at his alma mater. He is a registered member of PAMET, PAPSI, and the Philippine Association of Schools of Medical Technology and Public Health, Inc. Additionally, he holds a Lean Six Sigma White Belt certification, reflecting his commitment to continuous improvement in the field.

 

Areas of Research

Mr. Reigner Jay Escartin’s primary research area focuses on HIV-1, with a notable contribution to understanding the success rates and adherence to antiretroviral therapy (ART) among treatment-naïve patients in Davao City, Philippines. His work is highlighted by a ten-year retrospective cohort study that examined the long-term effectiveness of ART, analyzing patient adherence and identifying key factors that influence treatment outcomes. Through this research, Mr. Escartin has contributed valuable insights into the challenges faced by HIV-1 patients in adhering to therapy, particularly within local contexts. His findings aim to improve healthcare delivery and patient support systems, ultimately enhancing the quality of life for individuals living with HIV. Although still early in his career, his commitment to research and innovation in HIV-1 therapy provides a foundation for future development and collaboration in both clinical and public health settings. By addressing real-world issues in HIV treatment, his work is poised to drive further research and extension activities that could have a lasting impact on patient care and treatment protocols in the region.

Research and Innovations

Mr. Reigner Jay Escartin has completed one ongoing research project, though he currently has no consultancy or industry-sponsored projects, and the total cost of his projects is not applicable. He has published one journal article indexed in Scopus, Web of Science, or PubMed, but has no publications in SCI or SCIE indexes. He has not yet published any books, chapters, or conference proceedings, nor has he filed any patents. Additionally, he holds no editorial appointments in journals or conferences and has no citation index, H-index, or cumulative impact factor in the past three years. He has not presented at conferences, served as an invited speaker or resource person, or organized any research conferences or workshops. Mr. Escartin has not visited other countries for research, has not graduated any research scholars, and has no ongoing scholars under his supervision. He is also not involved in collaborative research activities, holds no awards or recognitions, and has not established functional MoUs with other institutions or industries. Lastly, he is not a member of any professional bodies.

Top Note Publications

Escartin, R. J. (2024, December). Success rates and adherence to antiretroviral therapy among treatment-naïve patients in Davao City, Philippines: A ten-year retrospective cohort study. Dialogues in Health, ISSN 2772-6533. https://doi.org/10.1016/j.dialog.2024.100195